X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - WN.COM - Health - 01/Oct 04:43

FDA Approves Inluriyo for Advanced Breast Cancer

TUESDAY, Sept. 30, 2025 (HealthDay News) --...

Articles similaires

Sorry! Image not available at this time

FDA Approves Inluriyo for Advanced Breast Cancer

wn.com - 01/Oct 08:13

TUESDAY, Sept. 30, 2025 (HealthDay News) --...

Sorry! Image not available at this time

FDA Approves Inluriyo for Advanced Breast Cancer

wn.com - 01/Oct 21:40

TUESDAY, Sept. 30, 2025 (HealthDay News) --...

Sorry! Image not available at this time

FDA Approves Inluriyo for Advanced Breast Cancer

drugs.com - 30/Sep 22:09

TUESDAY, Sept. 30, 2025 -- The U.S. Food and Drug Administration has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the...

Sorry! Image not available at this time

FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

drugs.com - 25/Sep 20:09

INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

drugs.com - 25/Sep 20:09

INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

Sorry! Image not available at this time

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

Sorry! Image not available at this time

FDA Approves INLURIYO (Imlunestrant): A Game-Changer for ESR1-Mutated Metastatic Breast Cancer Treatment | DelveInsight’s Perspective

wn.com - 27/Sep 02:02

"FDA approved INLURIYO (imlunestrant) by Eli Lilly, on September 25, 2025" The pharmaceutical landscape for metastatic breast cancer treatment has...

Sorry! Image not available at this time

FDA Approves INLURIYO (Imlunestrant): A Game-Changer for ESR1-Mutated Metastatic Breast Cancer Treatment | DelveInsight’s Perspective

wn.com - 27/Sep 02:02

"FDA approved INLURIYO (imlunestrant) by Eli Lilly, on September 25, 2025" The pharmaceutical landscape for metastatic breast cancer treatment has...

Sorry! Image not available at this time

FDA Approves Opzelura for Atopic Dermatitis in Children

wn.com - 30/Sep 08:38

MONDAY, Sept. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Opzelura cream 1.5 percent (ruxolitinib) for children...

Les derniers communiqués